{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:18:09Z","timestamp":1791987489251,"version":"4.4.0"},"reference-count":167,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T00:00:00Z","timestamp":1369094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T00:00:00Z","timestamp":1369094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"National Cancer Center Research and Development Fund 2011"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Res. Rev."],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1002\/med.21288","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T23:28:48Z","timestamp":1369178928000},"page":"280-300","source":"Crossref","is-referenced-by-count":541,"title":["FGF Receptors: Cancer Biology and Therapeutics"],"prefix":"10.1002","volume":"34","author":[{"given":"Masaru","family":"Katoh","sequence":"first","affiliation":[{"name":"Division of Integrative Omics and Bioinformatics; National Cancer Center; 5-1-1 Tsukiji Chuo Ward Tokyo 104-0045 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Nakagama","sequence":"additional","affiliation":[{"name":"Division of Integrative Omics and Bioinformatics; National Cancer Center; 5-1-1 Tsukiji Chuo Ward Tokyo 104-0045 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,5,21]]},"reference":[{"key":"10.1002\/med.21288-BIB0001|med21288-cit-0001","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"2002","journal-title":"Science"},{"key":"10.1002\/med.21288-BIB0002|med21288-cit-0002","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJMra044389","article-title":"Tyrosine kinases as targets for cancer therapy","volume":"353","author":"Krause","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1002\/med.21288-BIB0003|med21288-cit-0003","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/med.20070","article-title":"Targeting EGFR and HER-2 receptor tyrosine kinases for cancer drug discovery and development","volume":"26","author":"Kamath","year":"2006","journal-title":"Med Res Rev"},{"key":"10.1002\/med.21288-BIB0004|med21288-cit-0004","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","article-title":"EGFR antagonists in cancer treatment","volume":"358","author":"Ciardiello","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1002\/med.21288-BIB0005|med21288-cit-0005","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cardiores.2004.12.002","article-title":"The biology of vascular endothelial growth factors","volume":"65","author":"Tammela","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1002\/med.21288-BIB0006|med21288-cit-0006","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc2403","article-title":"VEGF-targeted therapy: Mechanisms of anti-tumour activity","volume":"8","author":"Ellis","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1002\/med.21288-BIB0007|med21288-cit-0007","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","article-title":"Cellular signaling by fibroblast growth factor receptors","volume":"16","author":"Eswarakumar","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1002\/med.21288-BIB0008|med21288-cit-0008","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The FGF family: Biology, pathophysiology and therapy","volume":"8","author":"Beenken","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1002\/med.21288-BIB0009|med21288-cit-0009","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/jcp.10472","article-title":"Anaplastic lymphoma kinase proteins in growth control and cancer","volume":"199","author":"Pulford","year":"2004","journal-title":"J Cell Physiol"},{"key":"10.1002\/med.21288-BIB0010|med21288-cit-0010","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer","volume":"363","author":"Kwak","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1002\/med.21288-BIB0011|med21288-cit-0011","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cytogfr.2005.05.010","article-title":"RET tyrosine kinase signaling in development and cancer","volume":"16","author":"Arighi","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1002\/med.21288-BIB0012|med21288-cit-0012","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2174\/092986711794088308","article-title":"Development of RET kinase inhibitors for targeted cancer therapy","volume":"18","author":"Mologni","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1002\/med.21288-BIB0013|med21288-cit-0013","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ncponc0558","article-title":"Mechanisms of disease: Oncogene addiction-A rationale for molecular targeting in cancer therapy","volume":"3","author":"Weinstein","year":"2006","journal-title":"Nature Clin Pract Oncol"},{"key":"10.1002\/med.21288-BIB0014|med21288-cit-0014","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc2559","article-title":"Targeting cancer with small molecule kinase inhibitors","volume":"9","author":"Zhang","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1002\/med.21288-BIB0015|med21288-cit-0015","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ncponc1161","article-title":"Combined targeting of EGFR-dependent and VEGF-dependent pathways: Rationale, preclinical studies and clinical applications","volume":"5","author":"Tortora","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1002\/med.21288-BIB0016|med21288-cit-0016","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1248\/bpb.34.1774","article-title":"Receptor tyrosine kinases and targeted cancer therapeutics","volume":"34","author":"Takeuchi","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1002\/med.21288-BIB0017|med21288-cit-0017","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/med.20209","article-title":"ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective","volume":"32","author":"Saxena","year":"2012","journal-title":"Med Res Rev"},{"key":"10.1002\/med.21288-BIB0018|med21288-cit-0018","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4161\/cbt.6.6.4196","article-title":"Dysregulation of stem cell signaling network due to germline mutation, SNP, helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer","volume":"6","author":"Katoh","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"10.1002\/med.21288-BIB0019|med21288-cit-0019","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2217\/epi.09.43","article-title":"Epigenetic regulation of WNT signaling in chronic lymphocytic leukemia","volume":"2","author":"Bennett","year":"2010","journal-title":"Epigenomics"},{"key":"10.1002\/med.21288-BIB0020|med21288-cit-0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2217\/epi.10.19","article-title":"Role of epigenomics in ovarian and endometrial cancers","volume":"2","author":"Balch","year":"2010","journal-title":"Epigenomics"},{"key":"10.1002\/med.21288-BIB0021|med21288-cit-0021","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.drudis.2011.08.007","article-title":"Anti-VEGF and beyond: Shaping a new generation of anti-angiogenic therapies for cancer","volume":"16","author":"Bertolini","year":"2011","journal-title":"Drug Discov Today"},{"key":"10.1002\/med.21288-BIB0022|med21288-cit-0022","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.sbi.2005.09.002","article-title":"A protein canyon in the FGF-FGF receptor dimer selects from an a\u2032la carte menu of heparan sulfate motifs","volume":"15","author":"Mohammadi","year":"2005","journal-title":"Curr Opin Struct Biol"},{"key":"10.1002\/med.21288-BIB0023|med21288-cit-0023","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1074\/jbc.M111.279836","article-title":"Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells","volume":"287","author":"Masola","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1002\/med.21288-BIB0024|med21288-cit-0024","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cytogfr.2005.01.003","article-title":"Fibroblast growth factor signaling in tumorigenesis","volume":"16","author":"Grose","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1002\/med.21288-BIB0025|med21288-cit-0025","first-page":"233","article-title":"Cancer genomics and genetics of FGFR2","volume":"33","author":"Katoh","year":"2008","journal-title":"Int J Oncol"},{"key":"10.1002\/med.21288-BIB0026|med21288-cit-0026","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4161\/cbt.10.5.13023","article-title":"Blockade of FGF signaling: Therapeutic promise for ovarian cancer","volume":"10","author":"Ivan","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"10.1002\/med.21288-BIB0027|med21288-cit-0027","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: From development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1002\/med.21288-BIB0028|med21288-cit-0028","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.molmed.2011.01.012","article-title":"Targeting mutant fibroblast growth factor receptors in cancer","volume":"17","author":"Greulich","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1002\/med.21288-BIB0029|med21288-cit-0029","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11912-012-0225-0","article-title":"FGF receptor inhibitors: Role in cancer therapy","volume":"14","author":"Daniele","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"10.1002\/med.21288-BIB0030|med21288-cit-0030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10059-010-0080-5","article-title":"Asymmetric tyrosine kinase arrangements in activation or autophosphorylation of receptor tyrosine kinases","volume":"29","author":"Bae","year":"2010","journal-title":"Mol Cells"},{"key":"10.1002\/med.21288-BIB0031|med21288-cit-0031","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cytogfr.2005.01.007","article-title":"Mechanisms underlying differential responses to FGF signaling","volume":"16","author":"Dailey","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1002\/med.21288-BIB0032|med21288-cit-0032","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1021\/pr9010475","article-title":"Differential phosphoproteomics of fibroblast growth factor signaling: Identification of Src family kinase-mediated phosphorylation events","volume":"9","author":"Cunningham","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1002\/med.21288-BIB0033|med21288-cit-0033","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1002\/pmic.200700615","article-title":"Protein partners in the life history of activated fibroblast growth factor receptors","volume":"7","author":"Vecchione","year":"2007","journal-title":"Proteomics"},{"key":"10.1002\/med.21288-BIB0034|med21288-cit-0034","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2174\/138920111794295710","article-title":"Network of WNT and other regulatory signaling cascades in pluripotent stem cells and cancer stem cells","volume":"12","author":"Katoh","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1002\/med.21288-BIB0035|med21288-cit-0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1749-8104-3-35","article-title":"Neural tube derived Wnt signals cooperate with FGF signaling in the formation and differentiation of the trigeminal placodes","volume":"3","author":"Canning","year":"2008","journal-title":"Neural Dev"},{"key":"10.1002\/med.21288-BIB0036|med21288-cit-0036","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-213X-8-2","article-title":"FGF10 maintains distal lung bud epithelium and excessive signaling leads to progenitor state arrest, distalization, and goblet cell metaplasia","volume":"8","author":"Nyeng","year":"2008","journal-title":"BMC Dev Biol"},{"key":"10.1002\/med.21288-BIB0037|med21288-cit-0037","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2174\/138945010791170860","article-title":"The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness","volume":"11","author":"Wang","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1002\/med.21288-BIB0038|med21288-cit-0038","doi-asserted-by":"crossref","first-page":"e27684","DOI":"10.1371\/journal.pone.0027684","article-title":"Expression of DNMT1 and DNMT3a are regulated by GLI1 in human pancreatic cancer","volume":"6","author":"He","year":"2011","journal-title":"PLoS One"},{"key":"10.1002\/med.21288-BIB0039|med21288-cit-0039","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4149\/neo_2012_002","article-title":"Differentiation pathways in carcinogenesis and in chemo- and radioresistance","volume":"59","author":"Janikova","year":"2012","journal-title":"Neoplasma"},{"key":"10.1002\/med.21288-BIB0040|med21288-cit-0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/307131a0","article-title":"Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15","volume":"307","author":"Nusse","year":"1984","journal-title":"Nature"},{"key":"10.1002\/med.21288-BIB0041|med21288-cit-0041","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0092-8674(84)90383-0","article-title":"Tumorigenesis by mouse mammary tumor virus: Proviral activation of a cellular gene in the common integration region int-2","volume":"37","author":"Dickson","year":"1984","journal-title":"Cell"},{"key":"10.1002\/med.21288-BIB0042|med21288-cit-0042","first-page":"1269","article-title":"WNT and FGF gene clusters","volume":"21","author":"Katoh","year":"2002","journal-title":"Int J Oncol"},{"key":"10.1002\/med.21288-BIB0043|med21288-cit-0043","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1073\/pnas.92.6.2268","article-title":"Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2\/Fgf-3 transgenic mice","volume":"92","author":"Lee","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/med.21288-BIB0044|med21288-cit-0044","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1158\/0008-5472.CAN-09-4404","article-title":"Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer","volume":"70","author":"Pond","year":"2010","journal-title":"Cancer Res"},{"key":"10.1002\/med.21288-BIB0045|med21288-cit-0045","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/ng.990","article-title":"Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis","volume":"43","author":"March","year":"2011","journal-title":"Nat Genet"},{"key":"10.1002\/med.21288-BIB0046|med21288-cit-0046","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.4161\/cbt.5.9.3151","article-title":"Cross-talk of WNT and FGF signaling pathways at GSK3\u03b2 to regulate \u03b2-catenin and SNAIL signaling cascades","volume":"5","author":"Katoh","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1002\/med.21288-BIB0047|med21288-cit-0047","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2174\/138945008784911750","article-title":"WNT signaling in stem cell biology and regenerative medicine","volume":"9","author":"Katoh","year":"2008","journal-title":"Curr Drug Targets"},{"key":"10.1002\/med.21288-BIB0048|med21288-cit-0048","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.289.5481.950","article-title":"Inhibition of adipogenesis by Wnt signaling","volume":"289","author":"Ross","year":"2000","journal-title":"Science"},{"key":"10.1002\/med.21288-BIB0049|med21288-cit-0049","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1158\/1078-0432.CCR-06-2316","article-title":"WNT signaling pathway and stem cell signaling network","volume":"13","author":"Katoh","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1002\/med.21288-BIB0050|med21288-cit-0050","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/jid.2008.445","article-title":"A Wnt survival guide: From flies to human disease","volume":"129","author":"Chien","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1002\/med.21288-BIB0051|med21288-cit-0051","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1600-0609.2011.01592.x","article-title":"Physiological inhibitors of Wnt signaling","volume":"86","author":"Filipovich","year":"2011","journal-title":"Eur J Haematol"},{"key":"10.1002\/med.21288-BIB0052|med21288-cit-0052","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nrd2154","article-title":"Mining the Wnt pathway for cancer therapeutics","volume":"5","author":"Barker","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1002\/med.21288-BIB0053|med21288-cit-0053","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mce.2010.11.014","article-title":"The Wnt\/\u03b2-catenin pathway in adrenocortical development and cancer","volume":"332","author":"El Wakil","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1002\/med.21288-BIB0054|med21288-cit-0054","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrd2518","article-title":"Structural diversity of G protein-coupled receptors and significance for drug discovery","volume":"7","author":"Lagerstr\u00f6m","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1002\/med.21288-BIB0055|med21288-cit-0055","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.0712148105","article-title":"Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a","volume":"105","author":"Fukuda","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/med.21288-BIB0056|med21288-cit-0056","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1158\/1535-7163.MCT-09-0282","article-title":"Wnt\/Planar cell polarity signaling: A new paradigm for cancer therapy","volume":"8","author":"Wang","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/med.21288-BIB0057|med21288-cit-0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/dvdy.21991","article-title":"Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: Their implications in developmental morphogenesis and human diseases","volume":"239","author":"Minami","year":"2010","journal-title":"Dev Dyn"},{"key":"10.1002\/med.21288-BIB0058|med21288-cit-0058","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/BJ20101878","article-title":"Wnt3a stimulation elicits G-protein-coupled receptor properties of mammalian Frizzled proteins","volume":"433","author":"Koval","year":"2011","journal-title":"Biochem J"},{"key":"10.1002\/med.21288-BIB0059|med21288-cit-0059","first-page":"6116","article-title":"Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the \u03b2-catenin\/T-cell factor complex","volume":"63","author":"Shimokawa","year":"2003","journal-title":"Cancer Res"},{"key":"10.1002\/med.21288-BIB0060|med21288-cit-0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.emboj.7600460","article-title":"FGF20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development","volume":"24","author":"Chamorro","year":"2005","journal-title":"EMBO J"},{"key":"10.1002\/med.21288-BIB0061|med21288-cit-0061","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1054\/bjoc.2001.1813","article-title":"FGF-1 and FGF-2 modulate the E-cadherin\/catenin system in pancreatic adenocarcinoma cell lines","volume":"84","author":"El-Hariry","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1002\/med.21288-BIB0062|med21288-cit-0062","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gde.2005.12.007","article-title":"Balancing cell adhesion and Wnt signaling, the key role of \u03b2-catenin","volume":"16","author":"Brembeck","year":"2006","journal-title":"Curr Opin Genet Dev"},{"key":"10.1002\/med.21288-BIB0063|med21288-cit-0063","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1158\/0008-5472.CAN-07-2325","article-title":"Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating \u03b2-catenin signaling","volume":"68","author":"Pai","year":"2008","journal-title":"Cancer Res"},{"key":"10.1002\/med.21288-BIB0064|med21288-cit-0064","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1128\/MCB.00550-10","article-title":"Mitogen-activated protein kinases promote WNT\/\u03b2-catenin signaling via phosphorylation of LRP6","volume":"31","author":"\u010cervenka","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1002\/med.21288-BIB0065|med21288-cit-0065","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.devcel.2009.11.006","article-title":"Cell cycle control of Wnt receptor activation","volume":"17","author":"Davidson","year":"2009","journal-title":"Dev Cell"},{"key":"10.1002\/med.21288-BIB0066|med21288-cit-0066","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1242\/dev.057323","article-title":"FGF\/MAPK\/Ets signaling renders pigment cell precursors competent to respond to Wnt signal by directly controlling Ci-Tcf transcription","volume":"138","author":"Squarzoni","year":"2011","journal-title":"Development"},{"key":"10.1002\/med.21288-BIB0067|med21288-cit-0067","doi-asserted-by":"crossref","first-page":"e29159","DOI":"10.1371\/journal.pone.0029159","article-title":"Polarized endocytosis of the keratinocyte growth factor receptor in migrating cells: Role of SRC-signaling and cortactin","volume":"6","author":"Belleudi","year":"2011","journal-title":"PLoS One"},{"key":"10.1002\/med.21288-BIB0068|med21288-cit-0068","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nature Rev Cancer"},{"key":"10.1002\/med.21288-BIB0069|med21288-cit-0069","first-page":"1677","article-title":"Epithelial-mesenchymal transition in gastric cancer","volume":"27","author":"Katoh","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1002\/med.21288-BIB0070|med21288-cit-0070","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tig.2009.04.001","article-title":"Evolutionary history of the Snail\/Scratch superfamily","volume":"25","author":"Barrallo-Gimeno","year":"2009","journal-title":"Trends Genet"},{"key":"10.1002\/med.21288-BIB0071|med21288-cit-0071","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ncponc1089","article-title":"Mechanisms of disease: Epithelial-mesenchymal transition-Does cellular plasticity fuel neoplastic progression","volume":"5","author":"Turley","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1002\/med.21288-BIB0072|med21288-cit-0072","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ncb1173","article-title":"Dual regulation of Snail by GSK-3\u03b2-mediated phosphorylation in control of epithelial-mesenchymal transition","volume":"6","author":"Zhou","year":"2004","journal-title":"Nat Cell Biol"},{"key":"10.1002\/med.21288-BIB0073|med21288-cit-0073","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1086\/301855","article-title":"Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations","volume":"62","author":"Paznekas","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1002\/med.21288-BIB0074|med21288-cit-0074","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.canlet.2011.06.009","article-title":"Overexpressed fibroblast growth factor receptor 2 in the invasive front of colorectal cancer: A potential therapeutic target in colorectal cancer","volume":"309","author":"Matsuda","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1002\/med.21288-BIB0075|med21288-cit-0075","doi-asserted-by":"crossref","first-page":"651","DOI":"10.18632\/oncotarget.199","article-title":"Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget","volume":"1","author":"Zlobec","year":"2010","journal-title":"Oncotarget"},{"key":"10.1002\/med.21288-BIB0076|med21288-cit-0076","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ceb.2005.08.001","article-title":"Molecular requirements for epithelial-mesenchymal transition during tumor progression","volume":"17","author":"Huber","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"10.1002\/med.21288-BIB0077|med21288-cit-0077","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1038\/sj.onc.1208927","article-title":"TGF-\u03b2 and epithelial-to-mesenchymal transitions","volume":"24","author":"Zavadil","year":"2005","journal-title":"Oncogene"},{"key":"10.1002\/med.21288-BIB0078|med21288-cit-0078","first-page":"271","article-title":"Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA","volume":"22","author":"Katoh","year":"2008","journal-title":"Int J Mol Med"},{"key":"10.1002\/med.21288-BIB0079|med21288-cit-0079","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2174\/156652409789105570","article-title":"Hedgehog target genes: Mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation","volume":"9","author":"Katoh","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1002\/med.21288-BIB0080|med21288-cit-0080","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1128\/MCB.02317-05","article-title":"Selective modulation of Hedgehog\/GLI target gene expression by epidermal growth factor signaling in human keratinocytes","volume":"26","author":"Kasper","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1002\/med.21288-BIB0081|med21288-cit-0081","first-page":"515","article-title":"Frequent up-regulation of WNT5A mRNA in primary gastric cancer","volume":"9","author":"Saitoh","year":"2002","journal-title":"Int J Mol Med"},{"key":"10.1002\/med.21288-BIB0082|med21288-cit-0082","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1242\/dev.008250","article-title":"Wnt5a is required for proper mammary gland development and TGF-\u03b2-mediated inhibition of ductal growth","volume":"134","author":"Roarty","year":"2007","journal-title":"Development"},{"key":"10.1002\/med.21288-BIB0083|med21288-cit-0083","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3892\/ijmm_00000190","article-title":"Transcriptional mechanisms of WNT5A based on NF-\u03baB, Hedgehog, TGF\u03b2, and Notch signaling cascades","volume":"23","author":"Katoh","year":"2009","journal-title":"Int J Mol Med"},{"key":"10.1002\/med.21288-BIB0084|med21288-cit-0084","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.yexcr.2011.03.017","article-title":"Mammary branch initiation and extension are inhibited by separate pathways downstream of TGF\u03b2 in culture","volume":"317","author":"Pavlovich","year":"2011","journal-title":"Exp Cell Res"},{"key":"10.1002\/med.21288-BIB0085|med21288-cit-0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jss.2011.09.020","article-title":"Contribution of epithelial-to-mesenchymal transition and cancer stem cells to pancreatic cancer progression","volume":"173","author":"Krantz","year":"2012","journal-title":"J Surg Res"},{"key":"10.1002\/med.21288-BIB0086|med21288-cit-0086","doi-asserted-by":"crossref","first-page":"17259","DOI":"10.1074\/jbc.M700075200","article-title":"The Wnt5A\/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition","volume":"282","author":"Dissanayake","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1002\/med.21288-BIB0087|med21288-cit-0087","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/carcin\/bgl255","article-title":"WNT5A-target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer","volume":"28","author":"Ripka","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1002\/med.21288-BIB0088|med21288-cit-0088","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10911-011-9205-5","article-title":"Wnt5a as an effector of TGF\u03b2 in mammary development and cancer","volume":"16","author":"Serra","year":"2011","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1002\/med.21288-BIB0089|med21288-cit-0089","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/nature05887","article-title":"Genome-wide association study identifies novel breast cancer susceptibility loci","volume":"447","author":"Easton","year":"2007","journal-title":"Nature"},{"key":"10.1002\/med.21288-BIB0090|med21288-cit-0090","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/bcr1793","article-title":"Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases","volume":"9","author":"Huijts","year":"2007","journal-title":"Breast Cancer Res"},{"key":"10.1002\/med.21288-BIB0091|med21288-cit-0091","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/hmg\/ddp078","article-title":"FGFR2 variants and breast cancer risk: Fine-scale mapping using African American studies and analysis of chromatin conformation","volume":"18","author":"Udler","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1002\/med.21288-BIB0092|med21288-cit-0092","doi-asserted-by":"crossref","first-page":"8000","DOI":"10.1158\/1078-0432.CCR-08-0975","article-title":"Genetic susceptibility loci for breast cancer by estrogen receptor status","volume":"14","author":"Garcia-Closas","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1002\/med.21288-BIB0093|med21288-cit-0093","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/bcr2917","article-title":"Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10","volume":"13","author":"Huijts","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1002\/med.21288-BIB0094|med21288-cit-0094","doi-asserted-by":"crossref","first-page":"e1001183","DOI":"10.1371\/journal.pgen.1001183","article-title":"Common genetic variants and modification of penetrance of BRCA2-associated breast cancer","volume":"6","author":"Gaudet","year":"2010","journal-title":"PLoS Genet"},{"key":"10.1002\/med.21288-BIB0095|med21288-cit-0095","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10549-010-1032-7","article-title":"Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North China","volume":"125","author":"Chen","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/med.21288-BIB0096|med21288-cit-0096","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2011-10-383380","article-title":"FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma","volume":"119","author":"Ma","year":"2012","journal-title":"Blood"},{"key":"10.1002\/med.21288-BIB0097|med21288-cit-0097","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1586\/era.10.128","article-title":"Genetic alterations of FGF receptors: An emerging field in clinical cancer diagnostics and therapeutics","volume":"10","author":"Katoh","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1002\/med.21288-BIB0098|med21288-cit-0098","doi-asserted-by":"crossref","first-page":"62ra93","DOI":"10.1126\/scitranslmed.3001451","article-title":"Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer","volume":"2","author":"Weiss","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1002\/med.21288-BIB0099|med21288-cit-0099","first-page":"4360","article-title":"Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: Definition of phenotypic groups","volume":"57","author":"Courjal","year":"1997","journal-title":"Cancer Res"},{"key":"10.1002\/med.21288-BIB0100|med21288-cit-0100","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/gutjnl-2011-301839","article-title":"A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets","volume":"61","author":"Deng","year":"2012","journal-title":"Gut"},{"key":"10.1002\/med.21288-BIB0101|med21288-cit-0101","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/onc.2009.489","article-title":"Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets","volume":"29","author":"Turner","year":"2010","journal-title":"Oncogene"},{"key":"10.1002\/med.21288-BIB0102|med21288-cit-0102","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/emmm.201100122","article-title":"ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium","volume":"3","author":"Holland","year":"2011","journal-title":"EMBO Mol Med"},{"key":"10.1002\/med.21288-BIB0103|med21288-cit-0103","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2012.09.017","article-title":"Cancer genetics and genomics of human FOX family genes","volume":"328","author":"Katoh","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1002\/med.21288-BIB0104|med21288-cit-0104","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.humpath.2009.11.003","article-title":"8p11 myeloproliferative syndrome: A review","volume":"41","author":"Jackson","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1002\/med.21288-BIB0105|med21288-cit-0105","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/modpathol.2011.98","article-title":"FOXO1-FGFR1 fusion and amplification in a solid variant of alveolar rhabdomyosarcoma","volume":"24","author":"Liu","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1002\/med.21288-BIB0106|med21288-cit-0106","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/sj.leu.2403347","article-title":"Targeting FGFR3 in multiple myeloma: Inhibition of t(4;14)-positive cells by SU5402 and PD173074","volume":"18","author":"Grand","year":"2004","journal-title":"Leukemia"},{"key":"10.1002\/med.21288-BIB0107|med21288-cit-0107","first-page":"8371","article-title":"Fusion of ETV6 to fibroblast growth factor receptor 3 in peripheral T-cell lymphoma with a t(4;12)(p16;p13) chromosomal translocation","volume":"61","author":"Yagasaki","year":"2001","journal-title":"Cancer Res"},{"key":"10.1002\/med.21288-BIB0108|med21288-cit-0108","first-page":"579","article-title":"Recombination cluster around FGFR2-WDR11-HTPAPL locus on human chromosome 10q26","volume":"11","author":"Katoh","year":"2003","journal-title":"Int J Mol Med"},{"key":"10.1002\/med.21288-BIB0109|med21288-cit-0109","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1126\/science.1220834","article-title":"Transforming fusions of FGFR and TACC genes in human glioblastoma","volume":"337","author":"Singh","year":"2012","journal-title":"Science"},{"key":"10.1002\/med.21288-BIB0110|med21288-cit-0110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ng0994-98","article-title":"Mutations in the FGFR2 gene cause Crouzon syndrome","volume":"8","author":"Reardon","year":"1994","journal-title":"Nat Genet"},{"key":"10.1002\/med.21288-BIB0111|med21288-cit-0111","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ng1194-275","article-title":"Jackson-Weiss and Crouzon syndromes are allelic with mutations in FGFR2","volume":"8","author":"Jabs","year":"1994","journal-title":"Nat Genet"},{"key":"10.1002\/med.21288-BIB0112|med21288-cit-0112","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng0295-165","article-title":"Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome","volume":"9","author":"Wilkie","year":"1995","journal-title":"Nat Genet"},{"key":"10.1002\/med.21288-BIB0113|med21288-cit-0113","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/ng0295-173","article-title":"Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes","volume":"9","author":"Rutland","year":"1995","journal-title":"Nat Genet"},{"key":"10.1002\/med.21288-BIB0114|med21288-cit-0114","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ng0896-492","article-title":"FGFR2 mutations in Beare-Stevenson cutis gyrata syndrome","volume":"13","author":"Przylepa","year":"1996","journal-title":"Nat Genet"},{"key":"10.1002\/med.21288-BIB0115|med21288-cit-0115","doi-asserted-by":"crossref","first-page":"8713","DOI":"10.1073\/pnas.0803379105","article-title":"Drug-sensitive FGFR2 mutations in endometrial carcinoma","volume":"105","author":"Dutt","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/med.21288-BIB0116|med21288-cit-0116","doi-asserted-by":"crossref","first-page":"e30801","DOI":"10.1371\/journal.pone.0030801","article-title":"FGFR2 point mutations in 466 endometrioid endometrial tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features","volume":"7","author":"Byron","year":"2012","journal-title":"PLoS One"},{"key":"10.1002\/med.21288-BIB0117|med21288-cit-0117","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1158\/1541-7786.MCR-08-0021","article-title":"Loss-of- function FGFR2 mutations in melanoma","volume":"7","author":"Gartside","year":"2009","journal-title":"Mol Cancer Res"},{"key":"10.1002\/med.21288-BIB0118|med21288-cit-0118","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1200\/JCO.2005.05.1771","article-title":"Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas","volume":"24","author":"Hern\u00e1ndez","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1002\/med.21288-BIB0119|med21288-cit-0119","first-page":"3395","article-title":"Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models","volume":"119","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1002\/med.21288-BIB0120|med21288-cit-0120","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/jid.2009.97","article-title":"FGFR2 abnormalities underlie a spectrum of bone, skin, and cancer pathologies","volume":"129","author":"Katoh","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1002\/med.21288-BIB0121|med21288-cit-0121","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1002\/ajmg.a.33703","article-title":"Genetic basis of potential therapeutic strategies for craniosynostosis","volume":"152A","author":"Melville","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1002\/med.21288-BIB0122|med21288-cit-0122","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3892\/ijmm_00000132","article-title":"FGFR2-related pathogenesis and FGFR2-targeted therapeutics","volume":"23","author":"Katoh","year":"2009","journal-title":"Int J Mol Med"},{"key":"10.1002\/med.21288-BIB0123|med21288-cit-0123","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/modpathol.2011.110","article-title":"FGFR2 alterations in endometrial carcinoma","volume":"24","author":"Gatius","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1002\/med.21288-BIB0124|med21288-cit-0124","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1093\/hmg\/ddp195","article-title":"The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects","volume":"18","author":"Ota","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1002\/med.21288-BIB0125|med21288-cit-0125","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2174\/156800909789057006","article-title":"The role of fibroblast growth factors in tumor growth","volume":"9","author":"Korc","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1002\/med.21288-BIB0126|med21288-cit-0126","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.yexcr.2009.11.019","article-title":"Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death","volume":"316","author":"Nilsson","year":"2010","journal-title":"Exp Cell Res"},{"key":"10.1002\/med.21288-BIB0127|med21288-cit-0127","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1517\/14728222.2011.566217","article-title":"Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy","volume":"15","author":"Heinzle","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"10.1002\/med.21288-BIB0128|med21288-cit-0128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2010.12.047","article-title":"Antiglioma effects of a new, low molecular mass, inhibitor of fibroblast growth factor","volume":"491","author":"Cuevas","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1002\/med.21288-BIB0129|med21288-cit-0129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1006367032156","article-title":"Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: Implications for combination treatment with photodynamic therapy","volume":"17","author":"Dimitroff","year":"1999","journal-title":"Invest New Drugs"},{"key":"10.1002\/med.21288-BIB0130|med21288-cit-0130","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1182\/blood-2004-10-3913","article-title":"CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma","volume":"105","author":"Trudel","year":"2005","journal-title":"Blood"},{"key":"10.1002\/med.21288-BIB0131|med21288-cit-0131","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1182\/blood-2007-02-074286","article-title":"Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome","volume":"110","author":"Chase","year":"2007","journal-title":"Blood"},{"key":"10.1002\/med.21288-BIB0132|med21288-cit-0132","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1535-7163.MCT-12-0999","article-title":"Activity of the fibroblast growth factor receptor inhibitors dovitinib (TKI258) and NVP-BGJ398 in human endometrial cancer cells","volume":"12","author":"Konecny","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/med.21288-BIB0133|med21288-cit-0133","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.bmcl.2003.12.019","article-title":"Orally active anti-proliferation agents: Novel diphenylamine derivatives as FGF-R2 autophosphorylation inhibitors","volume":"14","author":"Shimizu","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1002\/med.21288-BIB0134|med21288-cit-0134","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1053\/j.gastro.2006.08.030","article-title":"A novel molecular targeting compound as K-samII\/FGF-R2 phosphorylation inhibitor, Ki23057, for Scirrhous gastric cancer","volume":"131","author":"Nakamura","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1002\/med.21288-BIB0135|med21288-cit-0135","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.23131","article-title":"E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition","volume":"122","author":"Matsui","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1002\/med.21288-BIB0136|med21288-cit-0136","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1158\/1078-0432.CCR-08-0509","article-title":"Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma","volume":"14","author":"Huynh","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1002\/med.21288-BIB0137|med21288-cit-0137","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1158\/0008-5472.CAN-07-6307","article-title":"BIBF 1120: Triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy","volume":"68","author":"Hilberg","year":"2008","journal-title":"Cancer Res"},{"key":"10.1002\/med.21288-BIB0138|med21288-cit-0138","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccr.2009.09.028","article-title":"AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance","volume":"16","author":"O'Hare","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1002\/med.21288-BIB0139|med21288-cit-0139","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1158\/1535-7163.MCT-11-0450","article-title":"Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models","volume":"11","author":"Gozgit","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/med.21288-BIB0140|med21288-cit-0140","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1158\/0008-5472.CAN-09-2541","article-title":"MK-2461, a novel multitargeted kinase inhibitor, preferentially inhibits the activated c-Met receptor","volume":"70","author":"Pan","year":"2010","journal-title":"Cancer Res"},{"key":"10.1002\/med.21288-BIB0141|med21288-cit-0141","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1158\/0008-5472.CAN-10-2700","article-title":"E-3810 is a potent dual inhibitor of VEGFR and FGFR that exerts antitumor activity in multiple preclinical models","volume":"71","author":"Bello","year":"2011","journal-title":"Cancer Res"},{"key":"10.1002\/med.21288-BIB0142|med21288-cit-0142","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1158\/0008-5472.CAN-11-3034","article-title":"AZD4547: An orally bioavailable, potent and selective inhibitor of the FGFR tyrosine kinase family","volume":"72","author":"Gavine","year":"2012","journal-title":"Cancer Res"},{"key":"10.1002\/med.21288-BIB0143|med21288-cit-0143","doi-asserted-by":"crossref","first-page":"C469","DOI":"10.1152\/ajpcell.00452.2010","article-title":"NP603, a novel and potent inhibitor of FGFR1 tyrosine kinase, inhibits hepatic stellate cell proliferation and ameliorates hepatic fibrosis in rats","volume":"301","author":"Lin","year":"2011","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1002\/med.21288-BIB0144|med21288-cit-0144","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1021\/jm200285z","article-title":"N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): A novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity","volume":"54","author":"Lallemand","year":"2011","journal-title":"J Med Chem"},{"key":"10.1002\/med.21288-BIB0145|med21288-cit-0145","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/ijc.24763","article-title":"Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma","volume":"126","author":"Yashiro","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1002\/med.21288-BIB0146|med21288-cit-0146","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2011.03.015","article-title":"A FGFR2 inhibitor, Ki23057, enhances the chemosensitivity of drug-resistant gastric cancer cells","volume":"307","author":"Qiu","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1002\/med.21288-BIB0147|med21288-cit-0147","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1158\/1078-0432.CCR-11-0659","article-title":"Beyond VEGF: Inhibition of the fibroblast growth factor pathway and antiangiogenesis","volume":"17","author":"Lieu","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1002\/med.21288-BIB0148|med21288-cit-0148","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.onc.1210623","article-title":"Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models","volume":"27","author":"Desnoyers","year":"2008","journal-title":"Oncogene"},{"key":"10.1002\/med.21288-BIB0149|med21288-cit-0149","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1172\/JCI38017","article-title":"Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice","volume":"119","author":"Qing","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1002\/med.21288-BIB0150|med21288-cit-0150","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1158\/1078-0432.CCR-10-0531","article-title":"Monoclonal antibodies to FGFR2 effectively inhibit growth of gastric tumor xenografts","volume":"16","author":"Zhao","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1002\/med.21288-BIB0151|med21288-cit-0151","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bbrc.2007.09.007","article-title":"Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA","volume":"363","author":"Liang","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/med.21288-BIB0152|med21288-cit-0152","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4161\/cbt.7.2.5574","article-title":"RNA technology targeted to the WNT signaling pathway","volume":"7","author":"Katoh","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1002\/med.21288-BIB0153|med21288-cit-0153","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/hum.2007.147","article-title":"Advances in microRNAs: Implication for gene therapists","volume":"19","author":"Marquez","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1002\/med.21288-BIB0154|med21288-cit-0154","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/451414a","article-title":"The expanding world of small RNAs","volume":"451","author":"Grosshans","year":"2008","journal-title":"Nature"},{"key":"10.1002\/med.21288-BIB0155|med21288-cit-0155","doi-asserted-by":"crossref","first-page":"E223","DOI":"10.25011\/cim.v33i4.14225","article-title":"Translational applications of microRNA genes in medulloblastomas","volume":"33","author":"Ajeawung","year":"2010","journal-title":"Clin Invest Med"},{"key":"10.1002\/med.21288-BIB0156|med21288-cit-0156","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1742-4658.2011.08087.x","article-title":"miRNAs and regulation of cell signaling","volume":"278","author":"Ichimura","year":"2011","journal-title":"FEBS J"},{"key":"10.1002\/med.21288-BIB0157|med21288-cit-0157","doi-asserted-by":"crossref","first-page":"e18286","DOI":"10.1371\/journal.pone.0018286","article-title":"MicroRNA expression signatures of bladder cancer revealed by deep sequencing","volume":"6","author":"Han","year":"2011","journal-title":"PLoS One"},{"key":"10.1002\/med.21288-BIB0158|med21288-cit-0158","first-page":"1431","article-title":"Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance","volume":"26","author":"Li","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1002\/med.21288-BIB0159|med21288-cit-0159","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1096\/fj.10-171439","article-title":"Obesity short-circuits stemness gene network in human adipose multipotent stem cells","volume":"25","author":"Roldan","year":"2011","journal-title":"FASEB J"},{"key":"10.1002\/med.21288-BIB0160|med21288-cit-0160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1582-4934.2011.01282.x","article-title":"Functional analysis of microRNAs in human hepatocellular cancer stem cells","volume":"16","author":"Meng","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.1002\/med.21288-BIB0161|med21288-cit-0161","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ajhg.2007.09.021","article-title":"Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of \u03b1-synuclein","volume":"82","author":"Wang","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1002\/med.21288-BIB0162|med21288-cit-0162","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/jid.2011.55","article-title":"MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2","volume":"131","author":"Xu","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1002\/med.21288-BIB0163|med21288-cit-0163","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"10.1002\/med.21288-BIB0164|med21288-cit-0164","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/gb-2010-11-11-r114","article-title":"Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing","volume":"11","author":"Zhao","year":"2010","journal-title":"Genome Biol"},{"key":"10.1002\/med.21288-BIB0165|med21288-cit-0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1479-5876-9-119","article-title":"Deep sequencing of gastric carcinoma reveals somatic mutations relevant to personalized medicine","volume":"9","author":"Holbrook","year":"2011","journal-title":"J Transl Med"},{"key":"10.1002\/med.21288-BIB0166|med21288-cit-0166","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/ng.2246","article-title":"Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes","volume":"44","author":"Zang","year":"2012","journal-title":"Nat Genet"},{"key":"10.1002\/med.21288-BIB0167|med21288-cit-0167","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nature11217","article-title":"RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis","volume":"487","author":"Yu","year":"2012","journal-title":"Nature"}],"container-title":["Medicinal Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmed.21288","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmed.21288","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/med.21288\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T23:26:49Z","timestamp":1715383609000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/med.21288"}},"subtitle":["CANCER BIOLOGY AND THERAPEUTICS ON FGF RECEPTORS"],"short-title":[],"issued":{"date-parts":[[2013,5,21]]},"references-count":167,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"URL":"https:\/\/doi.org\/10.1002\/med.21288","archive":["Portico"],"relation":{},"ISSN":["0198-6325"],"issn-type":[{"value":"0198-6325","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5,21]]}}}